Tech Company CollectionsBiotechnology Companies
List of Biotechnology Companies
or search all companiesSelect...
Select...
Loading...
Page 1 of NaN
Displaying companies
Brightstar Therapeutics is a biotechnology company focused on innovative treatment options that improve clinical outcomes and quality of life for people living with corneal and ocular surface diseases. | Lexington | KY | 1 - 10 | 2023 | |
Terragia Biofuel provides the technology to drive the next generation of biofuels. | Hanover | NH | 5 - 20 | 2022 | $6,000,000 |
Forward Therapeutics is a biopharmaceutical company dedicated to transforming the treatment of chronic inflammatory disorders. Forward Therapeutics is advancing a pipeline of novel, next-generation small molecule immune therapies. | Palm Beach Gardens | FL | 2 - 10 | 2022 | $50,000,000 |
Ryne Biotechnology focuses on developing therapies for neurodegenerative movement disorders. The company was founded in 2022 and is headquartered in Cambridge, Massachusetts, United States. | San Diego | CA | 5 - 10 | 2022 | $89,000,000 |
Elegens is a startup in the field of personal genomics and biotechnology based in Hong Kong. We focus on providing genetic testing services directly to the consumer, in which clients provide a laboratory-analyzed saliva sample to generate reports on the or | RI | 100 - 500 | 2021 | $5,000,000 | |
AmplifyBio is a biotechnology company that develops next-generation cell and gene therapies. The company's mission is to create pathways for novel treatment advances, cutting-edge technologies, and new research frontiers to advance medical breakthroughs, t | West Jefferson | OH | 200 - 500 | 2021 | $279,750,016 |
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline. | San Diego | CA | 20 - 50 | 2021 | $50,000,000 |
RosVivo Therapeutics is a biotechnology company it develops microRNA-based therapeutics for type 2 diabetes, obesity, fatty liver disease. RosVivo Therapeutics targets diseases with breakthrough therapies utilizing microRNA (miRNA) and small interfering-R | Reno | NV | 5 - 10 | 2021 | $5,453,000 |
Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. | Austin | TX | 50 - 200 | 2021 | $248,099,952 |
Fuse Biotherapeutics is a biotech company developing next-generation immune-modulating therapeutics for patients with cancers. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner such that potent resp | Los Angeles | CA | 5 - 10 | 2021 | $9,500,000 |
Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases. | Cambridge | MA | 50 - 200 | 2021 | $134,000,000 |
Replicate Bioscience creates novel oncology treatments to prevent and reverse drug resistance through a self-replicating RNA platform called SynRGY. By deploying SynRGY technology, the company aims to design novel treatments that prevent the occurrence of | San Diego | CA | 20 - 50 | 2021 | $46,000,000 |
Abata Therapeutics, a company focused on translating the biology of regulatory T cells (Tregs) into transformational medicines for patients living with progressive multiple sclerosis (MS) and other severe autoimmune and inflammatory diseases. | Cambridge | MA | 20 - 100 | 2021 | $95,000,000 |
Adcentrx is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. By combining the targeting precision of biologics and the disease fighting power of small | San Diego | CA | 20 - 50 | 2021 | $101,000,000 |
Stablix Therapeutics is a biotechnology company pioneering the field of Targeted Protein Stabilization (TPS). The company’s resorted platform generates heterobifunctional small molecules (RESTORACS) that recruit deubiquitinase enzymes to remove ubiquitin f | New York | NY | 20 - 100 | 2021 | $63,000,000 |
Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. Founded and incubated by MPM Capital, the company has developed proprietary pl | Boston | MA | 20 - 50 | 2021 | $156,000,000 |
Atavistik Bio is a pre-clinical biotechnology company pioneering the identification of metabolite-protein interactions that have the potential to lead to the discovery and development of first-in-class drug candidates powered by distinct allosteric control | Cambridge | MA | 20 - 50 | 2021 | $100,000,000 |
Chroma Medicine is a new genomic medicine company working on epigenetic editing. Chroma Medicine is pioneering a new class of genomic medicines that harness epigenetics, nature’s innate mechanism for gene regulation, to revolutionize the treatment of genet | Boston | MA | 100 - 500 | 2021 | $260,000,000 |
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by indust | Cambridge | MA | 500 - 1,000 | 2021 | $550,000,000 |
Versanis Bio is advancing bimagrumab, a human monoclonal antibody to the activin type II receptors that blocks the binding of ligands including activin A and myostatin. Bimagrumab has been studied by Novartis in more than a dozen controlled clinical trials | Oakland | CA | 10 - 50 | 2021 | $70,000,000 |
Aera was founded with a vision to unlock the potential of genetic medicines across a broad range of modalities and therapeutic areas. Our protein nanoparticle (PNP) delivery platform leverages the discovery of endogenous, human proteins that can self-assem | Boston | MA | 100 - 500 | 2021 | $193,000,000 |
20n Bio is a VC-backed start-up dedicated to the computational design of novel protein therapeutics. | Malvern | PA | 2 - 10 | 2021 | $3,300,000 |
Anavasi Diagnostics is a medical technology company that focuses on the development of molecular diagnostic testing. | Seattle | WA | 20 - 50 | 2021 | $23,500,000 |
Adtech is an innovative biotech firm that has developed a novel formulation of a sole-sourced synthetic cannabinoid therapeutic targeting glaucoma. The company was founded in 2021 and is based in Warwick, Rhode Island, United States. | Warwick | RI | 2 - 10 | 2021 | $5,982,000 |
Circular Genomics is a biotechnology and genomics company that develops RNA-based diagnostic and therapeutic assays to facilitate the treatment of psychiatric and neurological diseases. The company was founded in 2021 and is headquartered in Albuquerque, N | Albuquerque | NM | 5 - 20 | 2021 | $12,825,000 |
Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment. | Newton | MA | 5 - 10 | 2020 | $1,893,339 |
Taysha Gene Therapies is a developer of treatments to eradicate severe & life-threatening monogenic diseases of the central nervous system. Taysha Gene Therapies is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curati | Dallas | TX | 50 - 200 | 2020 | $543,000,000 |
Steel Therapeutics is an Iowa-based pharmaceutical company focused on increasing access to life-changing therapies that have a track record of efficacy from compounding pharmacies. | North Liberty | IA | 2 - 10 | 2020 | $5,128,000 |
Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease. Founded by world-renowned experts in renal disease, Walden is applying its unique, systems-based approach to address the intersection between the patholo | Cambridge | MA | 20 - 50 | 2020 | $51,000,000 |
Grove Biopharma is a biotechnology company offering a materials science solution to peptide therapeutic challenges, focused on the discovery and development of a novel class of “protein-like polymers” to treat significant unmet medical needs in chronic inf | Chicago | IL | 5 - 20 | 2020 | $10,500,000 |
Neomorph is a venture backed biotechnology company based in San Diego, California. The team at Neomorph is building a leading protein degradation company, focusing on ‘molecular glue’ degraders. Our mission at Neomorph is to use this technology to solve cr | San Diego | CA | 50 - 100 | 2020 | $109,000,000 |
GentiBio is a biotherapeutics company developing engineered regulatory T cells (EngTregs) programmed to treat autoimmune allergic diseases. The early-stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop e | Seattle | WA | 100 - 200 | 2020 | $177,000,000 |
Thinking beyond antibiotics to fight life-threatening bacterial infections | Columbus | OH | 10 - 50 | 2020 | $59,240,000 |
Graphite Bio is a next-generation gene editing company focused on the development of first-in-class therapies for patients suffering from life-threatening genetic diseases. The company’s platform harnesses the natural cellular process of homology directed | South San Francisco | CA | 100 - 500 | 2020 | $195,749,984 |
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both autoimmunity and cancer. They leverage the systematic target validation and clinical insights gained by its founders to identify new targets. Their intensive | Newton | MA | 10 - 50 | 2020 | $214,849,984 |
Enviral Tech is a biotechnology company that focuses on environmental viral building surveillance solutions. Its patented COVID surface testing and COVID air testing provide early coronavirus detection for the health of communities, by preventing new infec | Eugene | OR | 10 - 50 | 2020 | $1,500,000 |
Tagomics transform disease diagnosis through comprehensive multitopic profiling. | Cambridge | MA | 5 - 10 | 2020 | 8467582 GBP |
Coya Therapeutics is a clinical-stage biotechnology company developing first-in-class and best-in-class approaches utilizing adoptive regulatory T cells (Tregs) to target disease. The company’s proprietary CTreg (cryopreservation for Tregs) system is the f | Houston | TX | 1 - 10 | 2020 | $51,800,000 |
Gene therapy is entering a new era as the field moves forward. But current technologies cannot overcome the challenges of many diseases. Ascidian’s unique approach aims to unlock these doors and enable treatment for millions of patients worldwide. | Boston | MA | 20 - 50 | 2020 | $90,000,000 |
Archean Biologics is a biotechnology company that provides flu medication solutions for influenza. The company's formulation utilizes a basic biological system of the strain of the influenza virus and builds resistance against it to reduce morbidity and mo | New York | NY | 5 - 10 | 2020 | $4,499,992 |
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.” With several drug targets identified and | Boston | MA | 20 - 100 | 2020 | $199,000,000 |
Seranova Bio partners with clinicians and drug developers to develop companion diagnostics or therapeutics to treat autoimmune disease or other autoantibody-driven diseases. The company's REAP platform was developed to detect autoantibodies that recognize | South San Francisco | CA | 5 - 20 | 2020 | $15,049,985 |
SchoolCare delivers free health technology for K-12 public schools to help school nurses deliver care and keep students safe. It is a digital health platform for the largest and most consistent health delivery system in the country. Their mission is to wor | Brisbane | CA | 500 - 1,000 | 2020 | $574,885,568 |
Scorpion Therapeutics was founded to broaden the reach and impact of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Pre | Boston | MA | 50 - 200 | 2020 | $420,000,000 |
Adagio Therapeutics is developing best-in-class antibodies that can broadly neutralize SARS-CoV-2, SARS-CoV-1, and additional potentially emergent coronaviruses. They believe that antibodies will match or exceed the potency and coverage of conventional SAR | Waltham | MA | 50 - 200 | 2020 | $466,000,000 |
Tectonic is a privately held biotechnology company that aims to transform the discovery of novel GPCR-targeted drugs and unlock the therapeutic utility the most challenging receptors in the class. Tectonic’s founders are at the forefront of scientific rese | Watertown | MA | 13 - 100 | 2020 | $210,700,000 |
biftek.co is established by the founders of tarla.io and iklim.co who tries to find solutions to real world problems such as sustainable meat production and climate adaptation in the presence of exponential population growth and steady resource shortages. | Newark | NJ | 10 - 50 | 2020 | $1,505,000 |
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics. | Larkspur | CA | 10 - 50 | 2020 | $60,000,000 |
Story Health helps specialists to understand medical situations and make clinical decisions that are through virtual protocols. Story Health uses data from high-frequency sources to help clinicians understand and take action on the physiological effects of | Cupertino | CA | 20 - 50 | 2020 | $26,600,000 |
Bicara Therapeutics, a wholly-owned subsidiary of Biocon based in Boston, U.S., is developing a pipeline of bifunctional antibodies that exploit the recent advances in immuno-oncology. Bicara enables access to the thriving innovation ecosystem in the U.S. | Cambridge | MA | 20 - 100 | 2020 | $313,000,000 |
Renegade.bio is a biotechnology startup dedicated to developing and deploying high throughput diagnostics for the detection of novel infectious diseases. | Berkeley | CA | 20 - 50 | 2020 | $1,134,000 |
Biosim will accelerate the drug discovery process many-fold through its platform that combines cutting-edge ideas from scientific computing, AI and quantum chemistry. Our aim is to reduce the timescale of small-molecule drug discovery projects from years t | College Park | MD | 5 - 20 | 2020 | $12,250,000 |
Catamaran Bio is a biotechnology company that specializes in allogeneic immune cell therapies. It offers cell therapy company developing allogeneic, off-the-shelf products for patients with an unmet medical need. It was founded in 2020 and headquartered in | Boston | MA | 20 - 50 | 2020 | $42,000,000 |
Options MD is a Techstars company that provides personalized interventions for people with treatment-resistant illnesses. 30% of people with mental illnesses will be classified as doctors as \'treatment-resistant\', meaning that conventional treatment prot | West Hollywood | CA | 5 - 20 | 2020 | $4,150,000 |
Appia Bio is an early-stage biotechnology company based in Los Angeles, California. Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increas | Los Angeles | CA | 20 - 50 | 2020 | $52,000,000 |
RNAimmune is a biopharmaceutical company specializing in the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. The company leverages mRNA as a data carrier to instruct the human body to produce its own proteins capable of fightin | Gaithersburg | MD | 5 - 20 | 2020 | $39,350,000 |
Virus Geeks is a data-driven BioHealth technology company that develops health-centric initiatives to improve the quality of life through strategic partnerships across healthcare & biotechnology sectors. We help large populations gain access to molecular d | Dallas | TX | 200 - 500 | 2020 | $5,300,000 |
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer. Verismo’s cellular therapy, known as KIR-CAR, is designed to provide a “natural stimulation” to T cells without triggering th | Philadelphia | PA | 5 - 20 | 2020 | $40,000,000 |
Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients. Its proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15 | Los Angeles | CA | 50 - 100 | 2020 | $186,000,000 |
Aspargo Laboratories commercialize the rights of an oral suspension spray formulation of erectile dysfunction medication Sildenafil citrate. Spray formulation offers convenient drug administration, flexible-dose titration, and accessibility for patients wi | Englewood | NJ | 5 - 10 | 2020 | $67,900,000 |
Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases.
The Company's proprietary ARC-sparX platform separates the tumor-recognitio | Gaithersburg | MD | 50 - 100 | 2020 | $422,000,000 |
Curative, Inc. is a healthcare startup company best known for scaling COVID-19 testing and COVID-19 vaccinations during the COVID-19 pandemic. Headquartered in San Dimas, California, and operating throughout the United States, the company was founded in Ja | San Dimas | CA | 500 - 2,000 | 2020 | $8,000,000 |
Foresight Diagnostics develops novel technology created to detect cancers earlier from a simple blood draw. | Aurora | CO | 20 - 100 | 2020 | $104,250,000 |
Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology. The company develops a protein engineering platform designed for multispecific therapies. | San Diego | CA | 20 - 50 | 2020 | $93,000,000 |
Lengo Therapeutics a biopharmaceutical company focused on the discovery and development of cancer treatments. Lengo works to identify several mutations in cancers that were not well addressed by existing therapeutics, helping medical practitioners and phar | San Diego | CA | 10 - 50 | 2020 | $15,000,000 |
Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using our IMPACT™ platform, we are addressing the central challenges of biologics discovery | Cambridge | MA | 20 - 100 | 2020 | $222,000,000 |
Revelation Biosciences develops immunologic therapeutics and diagnostics designed to make the world a healthier place. | San Diego | CA | 5 - 20 | 2020 | $51,561,288 |
Forge Biologics is a gene therapy development engine, focused on enabling access to life-changing gene therapies and helping bring them from an idea into reality. The company partners with innovators in the gene therapy community: scientists, physicians, b | Columbus | OH | 200 - 500 | 2020 | $330,000,000 |
Sonoma Biotherapeutics is a company invloved the development of adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is focused on developing its best-in-class | South San Francisco | CA | 100 - 500 | 2020 | $365,000,000 |
Jellatech is a B2B biotech business based in Raleigh, NC, and with R&D in Wageningen, Netherlands. Jellatech is producing high-quality, pure, animal-free collagen and gelatin. Founded by a group of innovators, dreamers, entrepreneurs, and scientists, Jella | Raleigh | NC | 5 - 20 | 2020 | $9,000,000 |
ANA Therapeutics is a developer of a novel coronavirus vaccine intended to save human lives. It is developing therapeutics to solve the coronavirus pandemic using Niclosamide that enables medical practitioners to treat patients suffering from COVID-19. It | San Mateo | CA | 2 - 10 | 2020 | $5,000,000 |
Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company founded by Catalys Pacific committed to developing best-in-class, novel therapy for the treatment of hypertension. The Company is driven to bring a targeted approach to the m | Radnor | PA | 20 - 50 | 2020 | $278,000,000 |
Focus X Therapeutics Inc is a corporation currently based in Sammamish, Washington, United States. It has been founded in 2020 by Fa Liu. | Sammamish | WA | 1 - 10 | 2020 | |
Orphion Therapeutics is focused on the development of novel gene therapies for the treatment of rare and serious genetic disorders. It was founded and is led by an executive management team experienced in drug development with the backing of respected heal | Great Neck | NY | 2 - 10 | 2020 | $5,332,500 |
ImmuneID is a precision immunology company using its proprietary platform to simultaneously identify and therapeutically target millions of antibody interactions that drive immune diseases. | Boston | MA | 20 - 50 | 2020 | $67,000,000 |
Centivax is a healthcare based agency that provides biotechnology, pharmaceutical, medical device manufacturing and therapeutics services. | South San Francisco | CA | 20 - 50 | 2020 | $14,200,000 |
BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders. | San Diego | CA | 20 - 50 | 2020 | $173,000,000 |
Pardes Biosciences is a biotechnology company that develops and commercializes direct-acting antivirals for the treatment of coronavirus. The Carlsbad, California-based company was established by Uri Lopatin in 2020. | Carlsbad | CA | 50 - 200 | 2020 | $126,614,992 |
Trident Bioscience is a biotech company that stays abreast of the latest technological trends in leading protein structure. | Mountain View | CA | 1 - 10 | 2020 | $125,000 |
Founded by Stuart Schreiber, Benjamin Cravatt, Stephanie Dougan, and Vasanthi Viswanathan, Kojin is accelerating a drug discovery platform that connects complex cell states to known biochemical processes such as ferroptosis, or iron-dependent cell death, a | Boston | MA | 20 - 50 | 2020 | $60,000,000 |
Faze Medicines is a biotechnology company harnessing the groundbreaking new science of biomolecular condensates to create medical breakthroughs. | Cambridge | MA | 20 - 50 | 2020 | $81,000,000 |
THEON Therapeutics is a patient-focused drug discovery company developing small molecule correctors of RNA pathobiology. The company was founded in 2020 and based in Boston, Massachusetts. | Boston | MA | 10 - 50 | 2020 | $13,374,999 |
Sora Neuroscience is a healthcare company that incorporates neuroscience into clinical practice. | Minneapolis | MN | 2 - 10 | 2020 | $2,717,500 |
MOMA Therapeutics operates as a biotechnology company. MOMA Therapeutics discover the next generation of precision medicines by targeting the molecular machines that underlie human disease. | Cambridge | MA | 20 - 100 | 2020 | $236,000,000 |
AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases. | Cambridge | MA | 50 - 200 | 2020 | $107,000,000 |
Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity. | Cambridge | MA | 50 - 200 | 2020 | $182,000,000 |
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities. It uses genomics, proteomics, structural biology, and computational chemistry to map and modulate protein communities. Interl | South San Francisco | CA | 20 - 100 | 2020 | $92,000,000 |
Manifold Bio is a biotechnology company that features a platform that enables multiplexed quantitation of protein therapeutic designs, generating unprecedented data throughout the drug development process to unlock measurement-driven design. The company is | Boston | MA | 20 - 50 | 2020 | $45,399,984 |
Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety. It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the | Seattle | WA | 50 - 100 | 2020 | $55,000,000 |
Acenxion Biosystems (ACXBIO) is a privately funded company developing automated systems for bacteria detection in blood cultures and phenotypic antimicrobial susceptibility testing (AST). Seamlessly fitting into current clinical workflows, Acenxion’s scala | Kansas City | KS | 5 - 20 | 2020 | $4,254,000 |
Palamedrix is the first company to leverage DNA nanotechnology for revolutionary advancements in life science and medicine. | San Diego | CA | 2 - 10 | 2020 | $6,000,000 |
AmbAgon Therapeutics is a developer of cancer molecule therapeutics. The company offers research of a small molecule that augments a tumor-suppressing protein. AmbAgon Therapeutics was founded by Christian Ottmann, Lucas Brunsveld, and Michelle Arkin. | San Francisco | CA | 20 - 100 | 2020 | $148,000,000 |
Atmofizer Technologies is a revolutionary clean tech company that brings clean air and water to the world. The company was founded in 2020 and is based in Miami Beach, FL. | Miami Beach | FL | 5 - 20 | 2020 | $375,000 |
Ocelot Bio brings new treatment options to patients with severe liver disease. The company was founded in 2020 and is headquartered in San Diego, California. | San Diego | CA | 10 - 50 | 2020 | $39,000,000 |
SalioGen Therapeutics advances in curative genetic therapies using its Exact DNA Integration Technology (EDIT) platform, a mammal-derived genome engineering technology. It is focused on providing durable, safe, and affordable non-viral gene therapies to mo | Cambridge | MA | 50 - 200 | 2020 | $135,000,000 |
Novel Farms uses microbial fermentation to develop cruelty-free, inexpensive and tunable bioscaffolds for the production of cell-based meat products. Novel Farms mission is to craft the taste and texture of the gourmet meats and transform cell-based meat c | Berkeley | CA | 2 - 10 | 2020 | $2,399,967 |
Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines for inflammatory diseases. | Palo Alto | CA | 20 - 50 | 2020 | $153,000,000 |
Castle Creek Biosciences is focused on developing and commercializing novel, personalized gene therapies for rare skin and connective tissue disorders with high unmet need. It was founded in 2015 and headquartered in Pennsylvania, United States. | Exton | PA | 20 - 50 | 2020 | $309,424,992 |
Medical device focused on treating brain circuits that underlie drug craving caused by environmental triggers for drug use addiction healthcare. People in recovery are constantly reminded of drug use by environmental cues (people, places, things linked to | Minneapolis | MN | 5 - 10 | 2019 | $1,166,946 |
BioPhy’s patent pending AI brings predictability and quantifiable risk to drug development | Philadelphia | PA | 10 - 50 | 2019 | $4,500,000 |
Loading...
Everything You Need, One Platform.
From job listings to startups, investors to funding rounds, and everything in between, Employbl puts the power in your hands. Why wait?
Start your free trial today!Stay Ahead of the Curve
Sign up for our newsletter to stay informed about the latest startups and trends in the tech market. Let Employbl be your guide to success.